Your shopping cart is currently empty

NTRC 0066-0 is an orally available, selective and potent inhibitor of threonine tyrosine kinase (TTK) that inhibits phosphorylation of TTK substrates and induces chromosome missegregation in cell lines and mice for cancer research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $149 | - | In Stock |
| Description | NTRC 0066-0 is an orally available, selective and potent inhibitor of threonine tyrosine kinase (TTK) that inhibits phosphorylation of TTK substrates and induces chromosome missegregation in cell lines and mice for cancer research. |
| Targets&IC50 | TTK:0.9 nM |
| In vitro | METHODS: To determine the potential relationship between aneuploidy, CIN, and sensitivity to TTK inhibitors, three cell lines that were relatively sensitive to NTRC 0066-0 and three less sensitive cell lines (colon cancer cell line HCT 116, colorectal adenocarcinoma cell line LoVo, and glioblastoma cell line A-172; cervical cancer cell line DoTc2 4520, osteosarcoma cell line MG-63, and ovarian adenocarcinoma cell line OVCAR-3 were selected in a broad cell panel screen and cell proliferation was measured. RESULTS: Colon cancer cell line HCT 116, colorectal adenocarcinoma cell line LoVo, and glioblastoma cell line A-172 were relatively sensitive to NTRC 0066-0, with IC50 values of 37 nM, 40 nM, and 51 nM, respectively. Cervical cancer cell line DoTc2 4520, osteosarcoma cell line MG-63, and ovarian adenocarcinoma cell line OVCAR-3 were less sensitive, with IC50 values of 117 nM, 135 nM, and 872 nM, respectively. [2] |
| Synonyms | NTRC0066-0, NTRC-0066-0, NTRC-00660, NTRC00660, NTRC 00660 |
| Molecular Weight | 565.71 |
| Formula | C33H39N7O2 |
| Cas No. | 1817791-73-3 |
| Smiles | O=C(NC=1C(=CC=CC1CC)CC)C=2C=CN3C4=NC(=NC=C4CCC23)NC5=CC=C(C=C5OC)N6CCN(C)CC6 |
| Relative Density. | 1.27 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 15 mg/mL (26.52 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.